June 13, Ken Terry
Much of the growth in health spending can be attributed to industry consolidation. The Federal Trade Commission (FTC) has tried to stop very few hospital mergers and, as health economist Paul Ginsburg has pointed out, federal antitrust policy doesn’t directly address hospital acquisitions of physician practices. However, the Medicare for All and Medicare expansion proposals create a new space for countering industry consolidation—if anything should come from these ideas.
June 12, André Blackman
Diversity and inclusion is a hot topic to discuss these days, but in the health/health care landscape, it absolutely cannot just stop there. We’re not dealing strictly with products here — there are actual lives at stake. How we hire, retain, and advance the talented individuals from underrepresented communities (women, people of color, LGBTQ, disabled) is the only way we will see widespread, effective innovation across the industry.
June 7, Luke Oakden-Rayner
Our typical methods of testing AI systems are inadequate and potentially unsafe—all of the headline-grabbing papers so far only do controlled experiments, so we are unaware of how the AI systems will perform on real patients. But one study actually went all the way: a company called Shanghai Wision AI Co. produced a system that detects polyps in the bowel wall during a colonoscopy and did a real clinical trial. But why has this paper been (for the most part) ignored?